MedTrace Logo

The Effect of A Dental Application to Promote Self-Administered Plaque Control: A RCT

NCT05073107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-02-15

No results posted yet for this study

Summary

Randomized Controlled Trial: to investigate the feasibility of the usage of a mobile dental application in the self-administration of plaque control in a two (2) parallel arm study with 52 subjects (n = 52). The study will take place over 2 visits (within 35 days): Visit 1 and 2.

Prospective Open Cohort Study: Patients referred to the Periodontology Department will be invited to participate in the study during the Oral Hygiene Phase. Routine clinical indices will be recorded at Visit 1 and Visit 2 before active non-surgical periodontal treatment commences.

Conditions

  • Periodontitis
  • Gingivitis
  • Plaque, Dental

Interventions

OTHER

Mobile Dental Application, Dental Monitoring ("DM")

o The Test group will be required to take intra-oral videos (which will be translated into photographs) using the DM application weekly and it will be monitored by the delegated team members: * Day 0 (To be taken at the clinic) * Day 7 (To be taken in the evening after brushing teeth) * Day 14 (To be taken in the evening after brushing teeth) * Day 21(To be taken in the evening after brushing teeth) * Day 28 (To be taken before study Visit 2) There is a window period of +1 day for the intra-oral videos.

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Jia Hui Fu, Dr · National University Centre for Oral Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-06
Primary Completion
2022-01-14
Completion
2022-01-14

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05073107 on ClinicalTrials.gov